Following a 25% Decline Over Last Year, Recent Gains May Please Fulgent Genetics, Inc. (NASDAQ:FLGT) Institutional Owners

Simply Wall StDec 4 18:27

All You Need to Know About Fulgent Genetics (FLGT) Rating Upgrade to Strong Buy

Yahoo FinanceNov 23 01:00

Fulgent Genetics Is Maintained at Neutral by Piper Sandler

Dow JonesNov 11 21:05 · Ratings

Fulgent Genetics Analyst Ratings

BenzingaNov 11 20:53 · Ratings

Piper Sandler Maintains Fulgent Genetics(FLGT.US) With Hold Rating, Cuts Target Price to $22

Futu NewsNov 11 20:34 · Ratings

Fulgent Genetics, Inc. (FLGT) Q3 2024 Earnings Call Transcript Summary

Futu NewsNov 11 15:40 · Conference Call